• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同大小的良性和恶性甲状腺结节阳性特征的变化趋势及重叠分析:基于中国甲状腺影像报告和数据系统

Alteration Trend and Overlap Analysis of Positive Features in Different-Sized Benign and Malignant Thyroid Nodules: Based on Chinese Thyroid Imaging Reporting and Data System.

作者信息

Qu Chen, Li Hong-Jian, Gao Qi, Zhang Jun-Chao, Li Wei-Min

机构信息

Department of Ultrasonography, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, People's Republic of China.

Department of Ultrasonography, Huai'an Cancer Hospital, Huai'an, Jiangsu, People's Republic of China.

出版信息

Int J Gen Med. 2024 May 6;17:1887-1895. doi: 10.2147/IJGM.S461076. eCollection 2024.

DOI:10.2147/IJGM.S461076
PMID:38736670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11086651/
Abstract

PURPOSE

This study aimed to investigate the alteration trends and overlaps of positive features in benign and malignant thyroid nodules of different sizes based on the Chinese Thyroid Imaging Reporting and Data System (C-TIRADS).

PATIENTS AND METHODS

1337 patients with 1558 thyroid nodules were retrospectively recruited from November 2021 to December 2023. These nodules were divided into three groups according to maximum diameter: A (≤10 mm), B (10-20 mm), and C (≥20 mm). C-TIRADS positive features were compared between benign and malignant thyroid nodules of different sizes. In addition, the trends of positive features with changes in nodule size among malignant thyroid nodules were analyzed.

RESULTS

The incidence of positive features in malignant thyroid nodules was higher than that in benign. As benign nodules grow, the incidence of all positive features showed a linear decreasing trend (Z values were 72.103, 101.081, 17.344, 33.909, and 129.304, P values < 0.001). With the size of malignant thyroid nodules increased, vertical orientation, solid, marked hypoechogenicity, and ill-defined/irregular margins/extrathyroidal extension showed a linear decreasing trend (Z = 148.854, 135.378, 8.590, and 69.239, respectively; P values < 0.05), while suspicious microcalcifications showed a linear increasing trend (Z = 34.699, P<0.001). In terms of overlapping characteristics, group A had a significantly higher overlapping rate than the other two groups, and the overlapping rate of solid indicators remained the highest among all three groups (P < 0.05).

CONCLUSION

Differences in positive features were observed between thyroid nodules of different sizes. Except for suspicious microcalcifications, the incidence of other four positive features decreased with increasing nodule size. In addition, a negative correlation was observed between the overlap rate and nodule size. These results may provide a basis for sonographers to upgrade or downgrade thyroid nodules based on their own experience.

摘要

目的

本研究旨在基于中国甲状腺影像报告和数据系统(C-TIRADS),探讨不同大小的良性和恶性甲状腺结节阳性特征的变化趋势及重叠情况。

患者与方法

回顾性纳入2021年11月至2023年12月期间的1337例患者的1558个甲状腺结节。这些结节根据最大直径分为三组:A组(≤10 mm)、B组(10 - 20 mm)和C组(≥20 mm)。比较不同大小的良性和恶性甲状腺结节的C-TIRADS阳性特征。此外,分析恶性甲状腺结节中阳性特征随结节大小变化的趋势。

结果

恶性甲状腺结节阳性特征的发生率高于良性结节。随着良性结节增大,所有阳性特征的发生率呈线性下降趋势(Z值分别为72.103、101.081、17.344、33.909和129.304,P值<0.001)。随着恶性甲状腺结节大小增加,垂直方向、实性、显著低回声及边界不清/不规则边缘/甲状腺外延伸呈线性下降趋势(Z值分别为148.854、135.378、8.590和69.239,P值<0.05),而可疑微钙化呈线性增加趋势(Z = 34.699,P<0.001)。在重叠特征方面,A组的重叠率显著高于其他两组,且实性指标的重叠率在三组中始终最高(P < 0.05)。

结论

不同大小的甲状腺结节在阳性特征上存在差异。除可疑微钙化外,其他四项阳性特征的发生率随结节大小增加而降低。此外,重叠率与结节大小呈负相关。这些结果可为超声检查人员根据自身经验对甲状腺结节进行升级或降级提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/f9d5a0f7a3e3/IJGM-17-1887-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/a87b8228cac9/IJGM-17-1887-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/14525c732220/IJGM-17-1887-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/7b4afc911d29/IJGM-17-1887-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/f9d5a0f7a3e3/IJGM-17-1887-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/a87b8228cac9/IJGM-17-1887-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/14525c732220/IJGM-17-1887-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/7b4afc911d29/IJGM-17-1887-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c9e/11086651/f9d5a0f7a3e3/IJGM-17-1887-g0004.jpg

相似文献

1
Alteration Trend and Overlap Analysis of Positive Features in Different-Sized Benign and Malignant Thyroid Nodules: Based on Chinese Thyroid Imaging Reporting and Data System.不同大小的良性和恶性甲状腺结节阳性特征的变化趋势及重叠分析:基于中国甲状腺影像报告和数据系统
Int J Gen Med. 2024 May 6;17:1887-1895. doi: 10.2147/IJGM.S461076. eCollection 2024.
2
Comparing Diagnostic Efficacy of C-TIRADS Positive Features on Different Sizes of Thyroid Nodules.比较C-TIRADS阳性特征对不同大小甲状腺结节的诊断效能。
Int J Gen Med. 2023 Aug 14;16:3483-3490. doi: 10.2147/IJGM.S416403. eCollection 2023.
3
[Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF Mutation in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance].[美国甲状腺协会指南、美国放射学会甲状腺影像报告和数据系统以及中国甲状腺影像报告和数据系统单独及联合BRAF突变在意义不明确的非典型性病变/意义不明确的滤泡性病变中的诊断价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Dec 30;45(6):921-928. doi: 10.3881/j.issn.1000-503X.15754.
4
A Prospective Study to Evaluate the Reliability of Thyroid Imaging Reporting and Data System in Differentiation between Benign and Malignant Thyroid Lesions.一项评估甲状腺影像报告和数据系统在鉴别甲状腺良恶性病变中可靠性的前瞻性研究。
J Clin Imaging Sci. 2016 Feb 26;6:5. doi: 10.4103/2156-7514.177551. eCollection 2016.
5
Large (≥3cm) thyroid nodules with benign cytology: Can Thyroid Imaging Reporting and Data System (TIRADS) help predict false-negative cytology?细胞学检查为良性的大(≥3cm)甲状腺结节:甲状腺影像报告和数据系统(TIRADS)能否有助于预测细胞学假阴性结果?
PLoS One. 2017 Oct 12;12(10):e0186242. doi: 10.1371/journal.pone.0186242. eCollection 2017.
6
Thyroid imaging reporting and data system (TIRADS) for ultrasound features of nodules: multicentric retrospective study in China.甲状腺影像报告和数据系统(TIRADS)在结节超声特征中的应用:中国多中心回顾性研究。
Endocrine. 2021 Apr;72(1):157-170. doi: 10.1007/s12020-020-02442-x. Epub 2020 Aug 27.
7
The Value of Chinese Thyroid Imaging Report and Data System Combined With Contrast-Enhanced Ultrasound Scoring in Differential Diagnosis of Benign and Malignant Thyroid Nodules.中文甲状腺影像报告和数据系统联合超声造影评分对甲状腺良恶性结节的鉴别诊断价值。
J Ultrasound Med. 2022 Jul;41(7):1753-1761. doi: 10.1002/jum.15858. Epub 2021 Oct 28.
8
Comparison of diagnostic performance and FNA management of the ACR-TIRADS and Chinese-TIRADS based on surgical histological evidence.基于手术组织学证据的ACR-TIRADS与中国-TIRADS诊断性能及细针穿刺活检管理的比较
Quant Imaging Med Surg. 2023 Mar 1;13(3):1711-1722. doi: 10.21037/qims-22-685. Epub 2023 Feb 23.
9
[The diagnostic performance of 2020 Chinese Ultrasound Thyroid Imaging Reporting and Data System in thyroid nodules].[2020版中国甲状腺影像报告和数据系统在甲状腺结节中的诊断效能]
Zhonghua Yi Xue Za Zhi. 2021 Dec 7;101(45):3748-3753. doi: 10.3760/cma.j.cn112137-20210401-00799.
10
Malignancy risk stratification in thyroid nodules with nondiagnostic results at cytologic examination: combination of thyroid imaging reporting and data system and the Bethesda System.甲状腺细针穿刺细胞学检查结果不明确的甲状腺结节恶性风险分层:甲状腺影像报告和数据系统与 Bethesda 系统的联合应用。
Radiology. 2015 Jan;274(1):287-95. doi: 10.1148/radiol.14140359. Epub 2014 Aug 18.

引用本文的文献

1
The predictive value of the ultrasound grayscale ratio for identifying malignant thyroid nodules.超声灰度比在鉴别甲状腺恶性结节中的预测价值。
Front Endocrinol (Lausanne). 2025 Aug 29;16:1665113. doi: 10.3389/fendo.2025.1665113. eCollection 2025.
2
Epidemiological and Pathogenic Characteristics of Benign and Malignant Thyroid Nodules Undergoing Ultrasonography for Health Checkup Population.健康体检人群中接受超声检查的甲状腺良恶性结节的流行病学及病原学特征
Int J Gen Med. 2025 May 28;18:2769-2779. doi: 10.2147/IJGM.S517851. eCollection 2025.

本文引用的文献

1
Comparing Diagnostic Efficacy of C-TIRADS Positive Features on Different Sizes of Thyroid Nodules.比较C-TIRADS阳性特征对不同大小甲状腺结节的诊断效能。
Int J Gen Med. 2023 Aug 14;16:3483-3490. doi: 10.2147/IJGM.S416403. eCollection 2023.
2
Comparison of postoperative bleeding using harmonic scalpel and LigaSure in thyroid surgery: a 15-year single-centre retrospective study.甲状腺手术中使用超声刀和血管闭合系统进行术后出血的比较:一项为期15年的单中心回顾性研究。
Med Glas (Zenica). 2023 Aug 1;20(2). doi: 10.17392/1629-23.
3
Comparative Study of C-TIRADS, ACR-TIRADS, and EU-TIRADS for Diagnosis and Management of Thyroid Nodules.
C-TIRADS、ACR-TIRADS和EU-TIRADS在甲状腺结节诊断与管理中的比较研究
Acad Radiol. 2023 Oct;30(10):2181-2191. doi: 10.1016/j.acra.2023.04.013. Epub 2023 May 23.
4
Diagnostic tests for medullary thyroid carcinoma: an umbrella review.甲状腺髓样癌的诊断检测:伞式综述。
Endocrine. 2023 Aug;81(2):183-193. doi: 10.1007/s12020-023-03326-6. Epub 2023 Mar 6.
5
Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study.六种基于超声的甲状腺滤泡性肿瘤风险分层系统的诊断性能:一项回顾性多中心研究。
Front Oncol. 2022 Oct 20;12:1013410. doi: 10.3389/fonc.2022.1013410. eCollection 2022.
6
Thyroidectomy for the Management of Differentiated Thyroid Carcinoma and their Outcome on Early Postoperative Complications: A 6-year Single-Centre Retrospective Study.甲状腺切除术治疗分化型甲状腺癌及其术后早期并发症的结果:一项 6 年单中心回顾性研究。
Chirurgia (Bucur). 2022 Oct;117(5):556-562. doi: 10.21614/chirurgia.2736.
7
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.第五版世界卫生组织头颈部肿瘤分类更新:2022 年世界卫生组织头颈部神经内分泌肿瘤分类概述。
Head Neck Pathol. 2022 Mar;16(1):123-142. doi: 10.1007/s12105-022-01435-8. Epub 2022 Mar 21.
8
Overview of the 2022 WHO Classification of Thyroid Neoplasms.2022 年世卫组织甲状腺肿瘤分类概述。
Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14.
9
The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020.全球甲状腺癌的流行病学概况:2020 年发病率和死亡率的 GLOBOCAN 估计。
Lancet Diabetes Endocrinol. 2022 Apr;10(4):264-272. doi: 10.1016/S2213-8587(22)00035-3. Epub 2022 Mar 7.
10
Cancer rate of Bethesda category II thyroid nodules.贝塞斯达分类II级甲状腺结节的癌症发生率。
Med Glas (Zenica). 2022 Feb 1;19(1). doi: 10.17392/1413-21.